Human alpha 2-plasmin inhibitor.
Aoki
N
N
First Department of Internal Medicine, Tokyo Medical and Dental University, Japan.
Sumi
Y
Y
Miura
O
O
Hirosawa
S
S
D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D016466:CHO Cells; D002460:Cell Line; D002846:Chromatography, Affinity / Q000379:methods; D006224:Cricetinae; D005822:Genetic Vectors; D006801:Humans; D007118:Immunoassay / Q000379:methods; D007202:Indicators and Reagents; D008969:Molecular Sequence Data; D008970:Molecular Weight; D016254:Mutagenesis, Insertional / Q000379:methods; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000302:isolation & purification / Q000378:metabolism; D015183:Restriction Mapping; D014162:Transfection / Q000379:methods; D000979:alpha-2-Antiplasmin / Q000096:biosynthesis / Q000302:isolation & purification* / Q000378:metabolism*
D007202:Indicators and Reagents; D011994:Recombinant Proteins; D000979:alpha-2-Antiplasmin